| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |